TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BIO

Bio-Rad Laboratories Inc

Healthcare · Medical Devices

381.00$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Bio-Rad Laboratories Inc (BIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 99 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BIO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
98 81 70 98 164 124 130 117 121 165 108 99 493
37 37 37 36 39 49 38 -38 44 43 41 41 169
16 16 15 15 16 16 15 -15 15 16 15 15 60
-74 – – – – – – – – – – – –
-2.5 -8.2 54 -680 221 57 44 -44 -102 254 -169 2.6 -14
44 42 40 42 64 43 34 46 32 46 30 32 140
-9.5 72 -43 -31 -56 -31 2.9 -115 -43 -34 -93 -67 -237
4.6 85,439 16 – 16 – – 49 63 – 33 16 –
-21 -200 -4.7 -101 -98 0.0 -102 -140 -53 -280 -48 -32 -412
-0.1 – – – -0.1 0.0 -0.1 -0.2 0.0 -0.2 -0.1 -0.2 -0.5
-27 -201 0.0 -97 -96 -26 -98 -136 -53 3.3 -44 -28 -121
68 -54 29 -26 4.5 78 33 -151 27 132 -23 9.5 145
54 39 30 55 100 81 96 71 89 119 78 67 353

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?